Switching biological disease-modifying antirheumatic drugs in patients with axial spondyloarthritis: results from a systematic literature review

OBJECTIVES: First, to investigate if switching biological disease-modifying antirheumatic drugs (bDMARDs) after the failure to prior bDMARD is efficacious in patients with axial spondyloarthritis (axSpA). Second, to evaluate the influence on this efficacy of (1) the reason to discontinue prior tumou...

Descripción completa

Detalles Bibliográficos
Autores principales: Navarro-Compán, Victoria, Plasencia-Rodríguez, Chamaida, de Miguel, Eugenio, Diaz del Campo, Petra, Balsa, Alejandro, Gratacós, Jordi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Spondyloarthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640114/
https://www.ncbi.nlm.nih.gov/pubmed/29071119
http://dx.doi.org/10.1136/rmdopen-2017-000524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640114/
https://www.ncbi.nlm.nih.gov/pubmed/29071119
http://dx.doi.org/10.1136/rmdopen-2017-000524

Ejemplares similares